Chase Investment Counsel’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,980	Closed	-$534K	–	133
2025 Q3	$534K	Hold	8,980	–	–	0.16%	96
2025 Q2	$411K	Hold	8,980	–	–	0.13%	108
2025 Q1	$432K	Hold	8,980	–	–	0.16%	98
2024 Q4	$454K	Hold	8,980	–	–	0.15%	99
2024 Q3	$572K	Sell	8,980 -1,555	-15%	-$100K	0.19%	82
2024 Q2	$624K	Sell	10,535 -1,520	-13%	-$84.1K	0.22%	88
2024 Q1	$693K	Hold	12,055	–	–	0.26%	87
2023 Q4	$687K	Hold	12,055	–	–	0.3%	80
2023 Q3	$578K	Sell	12,055 -4,155	-26%	-$213K	0.29%	78
2023 Q2	$843K	Hold	16,210	–	–	0.43%	60
2023 Q1	$878K	Buy	+16,210	New	+$915K	0.49%	59
2022 Q1	–	Sell	-22,285	Closed	-$1.81M	–	115
2021 Q4	$1.81M	Hold	22,285	–	–	0.72%	48
2021 Q3	$2.12M	Hold	22,285	–	–	0.91%	43
2021 Q2	$2.19M	Hold	22,285	–	–	0.91%	44
2021 Q1	$1.86M	Sell	22,285 -13,600	-38%	-$1.28M	0.85%	51
2020 Q4	$3.1M	Hold	35,885	–	–	1.37%	31
2020 Q3	$2.51M	Hold	35,885	–	–	1.25%	32
2020 Q2	$2.6M	Buy	+35,885	New	+$2.29M	1.32%	26
2019 Q4	–	Sell	-46,396	Closed	-$1.97M	–	109
2019 Q3	$1.97M	Hold	46,396	–	–	1.01%	39
2019 Q2	$2.4M	Hold	46,396	–	–	1.22%	34
2019 Q1	$2.57M	Hold	46,396	–	–	1.32%	32
2018 Q4	$1.95M	Hold	46,396	–	–	1.16%	32
2018 Q3	$3.23M	Hold	46,396	–	–	1.67%	23
2018 Q2	$2.65M	Hold	46,396	–	–	1.43%	30
2018 Q1	$2.55M	Hold	46,396	–	–	1.32%	33
2017 Q4	$2.6M	Hold	46,396	–	–	1.37%	33
2017 Q3	$2.84M	Hold	46,396	–	–	1.49%	32
2017 Q2	$2.48M	Hold	46,396	–	–	1.2%	35
2017 Q1	$2.24M	Hold	46,396	–	–	1.08%	35
2016 Q4	$1.85M	Hold	46,396	–	–	0.92%	40
2016 Q3	$2.25M	Buy	+46,396	New	+$2.2M	0.99%	38